AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease
Recruiting
N/AInterventional Study
Coronary Arterial Disease (CAD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
15 (estimated)
Sponsor
Amplitude Vascular Systems, Inc. · Industry
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
A prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Key Inclusion Criteria:
* ≥ 18 years of age
* Subjects with native coronary artery disease
* Left ventricular ejection fraction (LVEF) ≥ 35% within 6 months
* The target lesion must be a single de novo coronary lesion
* The target lesion stenosis of left anterior descending artery (LAD), right coro…
Key Inclusion Criteria:
* ≥ 18 years of age
* Subjects with native coronary artery disease
* Left ventricular ejection fraction (LVEF) ≥ 35% within 6 months
* The target lesion must be a single de novo coronary lesion
* The target lesion stenosis of left anterior descending artery (LAD), right coronary artery (RCA), left circumflex artery (LCX), or ramus intermedius (RI), or of their branches with Stenosis of ≥70% and \<100% or Stenosis ≥50% and \<70% with evidence of ischemia
* Lesion length must not exceed 44 mm
Key Exclusion Criteria:
* Subject experienced an acute Myocardial Infarction (MI), either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) within 30 days prior to index procedure.
* Subject has New York Heart Association (NYHA) class III or IV heart failure.
* Subject has renal failure with serum creatinine \>2.5 mg/dL, or chronic dialysis.
* Subject has a previous stent in the target vessel implanted within last six months.
* Unprotected LMCA diameter stenosis \>30%.
* Target lesion has a myocardial bridge.
* Target vessel is excessively tortuous, defined as the presence of 2 or more bends \>90 degrees or 3 or more bends \>75 degrees.
* Evidence of aneurysm in target vessel within 10 mm of the target lesion.
* Target lesion in ostial location (LAD, RCA, LCX, or RI, within 5 mm of ostium) or in an unprotected LMCA.
* Target lesion is a bifurcation with ostial diameter stenosis ≥30%.
* Any previous stent within 10 mm of the target lesion.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.